Hyderabad, India-based Aurobindo Pharma said that it will expand its facility at its East Windsor, New Jersey, campus to set up a manufacturing facility for injectable products. Aurobindo's U.S., business chief, Bob Cunard, said in an earnings briefing that "the company has the bandwidth to add manufacturing in the United...
Aurobindo Pharma, India, Scales Up to Meet U.S. Requirements
According to LiveMint, Hyderabad-based Aurobindo Pharma is planning to scale up its capacity as it expects more launches in its key U.S. market. It also plans to make India its sourcing hub for its generic drug business in Western Europe – a business that it had acquired from Actavis Plc....